Evolving Strategies for the Management of Diabetic Macular Edema

Evolving Strategies for the Management of Diabetic Macular Edema

Approved for 1.5 AMA PRA Category 1 Credits™!

Date & Time
Friday, October 17, 2014

6:00 - 6:45 PM Registration and Pre-Reception
6:45 - 8:15 PM Educational Session
8:15 PM Post-Reception

Location
W City Center
Great Room 1 - Plateau Level
172 W. Adams Street
Chicago, IL 60603

Grab the shuttle from the convention center! Details below.

Transportation
Complimentary shuttle service will be provided to transport attendees to the W City Center Hotel. The buses, operated by Ideal Transportation, will depart from the McCormick Place Convention Center at 5:30 PM and 6:00 PM. Should you be interested in utilizing this service, please meet your driver outside of Gate 26 at the South Building of the McCormick Place Convention Center. The buses will be marked with a sign in the front windshield titled "CME Dinner – Evolving Strategies for DME".

Faculty
Karl G. Csaky, MD, PhD - Moderator
Vitreoretinal Specialist
Texas Retina Institute
T. Boone Pickens Senior Scientist
Retina Foundation of the Southwest
Dallas, TX

David M. Brown, MD, FACS
Director, Greater Houston Retina Research Center
Retina Consultants of Houston, Methodist Hospital
Houston, TX

Nancy M. Holekamp, MD, PhD
Director of Retina Diseases
Center for Macular Degeneration
Pepose Vision Institute
Chesterfield, MO

Raj Maturi, MD
Associate Professor of Ophthalmology
Indiana School of Medicine
Indianapolis, IN

CME Information

Target Audience:

This certified CME activity is designed for general ophthalmologists.

Learning Objectives:

Upon completion of this activity, the participant should be able to:

• Discuss the pathophysiology and epidemiology of diabetic macular edema (DME)
• Differentiate existing DME therapy options from recent primary and secondary treatments
• Apply evidence-based medicine when treating macular edema
and Inflammation
• Evaluate the response or nonresponse to treatment: Decision tree modeling in treatment decisions
• Discuss important conditions to consider in using therapies in patients with significant comorbidities

Accreditation and Designation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Dulaney Foundation and Retina Today. The Dulaney Foundation is accredited by the ACCME to provide continuing education for physicians. The Dulaney Foundation designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Supported by an unrestricted educational grant from:

Jointly sponsored by:

This program is not affiliated with the official program of the Annual Meeting.